Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis
about
Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents.Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis.S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.The ongoing quest for biomarkers in Ankylosing Spondylitis.Calprotectin in rheumatic diseases.Clinical and Imaging Signs of Spondyloarthritis in First-Degree Relatives of HLA-B27-Positive Ankylosing Spondylitis Patients: The Pre-Spondyloarthritis (Pre-SpA) Cohort Study.Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohortAn update on biomarker discovery and use in axial spondyloarthritis.Unmet Needs in Axial Spondyloarthritis.Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease.Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis.Association of circulating calprotectin with lipid profile in axial spondyloarthritis
P2860
Q33880811-FD23E34A-40E4-443F-8218-AC77E7A26FCAQ35809286-E09C9858-7944-4E2E-B5C3-BF8439420BECQ36614247-EDB4B7C6-0A0A-4B27-935C-56FA79C5EBCBQ37364345-90BC88EE-0890-45C4-9E04-C5D2802DEA45Q37442813-9212B04B-9A5F-4AD2-AAE8-773AAC70F51BQ38607774-286A5C43-7DB3-4706-86A7-72BC499AC304Q39022858-E506C19C-89AA-411D-82E1-E4C866D5BE95Q40741048-58B26AF1-93F2-4224-9DAD-5331577C3F05Q42330283-6929AA16-7662-41F2-908C-B367F963D003Q47787817-CC4C0729-FC13-476E-8908-876E779FA53FQ48287506-4E6FC7C4-1E62-49A8-9AA7-24A5E4B1CCE9Q48773981-E51D62B7-92EC-4214-9A19-D8477AD6D8CEQ52594911-37BB7B3D-035C-4AC6-808A-2847E5AABF1EQ58743766-E2A20E8E-C469-4F90-9A53-F1C7C734B9FC
P2860
Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@ast
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@en
type
label
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@ast
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@en
prefLabel
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@ast
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@en
P2093
P2860
P1476
Calprotectin (S100A8/9) as ser ...... d peripheral spondyloarthritis
@en
P2093
Dominique Baeten
Jacqueline E Paramarta
Leen De Rycke
Maureen C Turina
Nataliya Yeremenko
P2860
P2888
P356
10.1186/S13075-014-0413-4
P577
2014-08-19T00:00:00Z
P5875
P6179
1002250565